Table 1

Characteristics of Acute Respiratory Distress Syndrome (ARDS) survivors included in primary analysis

Values (N=645)
Baseline demographic and clinical variables
 Age (years); mean±SD49±14
 Female sex; n (%)331 (51%)
 Hispanic/Latino; n (%)56 (9%)
 APACHE III; mean±SD85±26
Race; n (%)
 American Indian or Alaskan Native5 (1%)
 Asian8 (1%)
 White507 (77%)
 Black or African American104 (16%)
 Native Hawaiian or other Pacific Islander1 (<1%)
 Not reported17 (3%)
Lung injury category; n (%)
 Trauma32 (5%)
 Sepsis106 (16%)
 Multiple transfusion15 (2%)
 Aspiration72 (11%)
 Pneumonia387 (60%)
 Other38 (6%)
Comorbidities; n (%)
 Chronic dialysis14 (2%)
 Leukaemia (AML, CML, ALL, multiple myeloma)11 (2%)
 Non-Hodgkin's lymphoma5 (1%)
 Solid tumour with metastasis4 (1%)
 Immune suppression (within last 6 months)49 (8%)
 Hepatic failure (with coma or encephalopathy)3 (<1%)
 Cirrhosis24 (3%)
 Diabetes mellitus154 (24%)
 History of hypertension269 (42%)
 Prior myocardial infarction31 (5%)
 Congestive heart failure32 (5%)
 Peripheral vascular disease25 (4%)
 Prior stroke with sequelae10 (2%)
 Dementia3 (<1%)
 Chronic pulmonary disease73 (11%)
 Arthritis46 (7%)
 Peptic ulcer disease18 (3%)
Variables in the primary analysis
Residence prior to hospitalisation; n (%)
 Home independently589 (91%)
 Home with informal help36 (6%)
Requiring professional help at home OR residence at healthcare facility20 (3%)
 AIDS; n (%)10 (2%)
 Current smoker at time of hospital admission; n (%)269 (42%)
 Body mass index at the time of hospital admission; mean±SD30±8
Outcome
EQ-5D; median (IQR)0.77 (0.51–0.83)
  • ALL, acute lymphocytic leukemia; AML, acute myelogenous leukemia; CNL, chronic myelogenous leukemia.